These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13983345)

  • 1. The iodinated albuminlike component of the plasma of thyrotoxic patients.
    STANBURY JB; JANSSEN MA
    J Clin Endocrinol Metab; 1962 Oct; 22():978-88. PubMed ID: 13983345
    [No Abstract]   [Full Text] [Related]  

  • 2. An iodine compound associated with albumin in the plasma of thyrotoxic patients.
    CAMERON C; FLETCHER K
    Nature; 1959 Jan; 183(4654):116. PubMed ID: 13622712
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients.
    Spaulding SW; Burrow GN; Bermudez F; Himmelhoch JM
    J Clin Endocrinol Metab; 1972 Dec; 35(6):905-11. PubMed ID: 4634489
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatizing thyroid carcinoma: evelopment of thyrotoxic crisis and behaviour of iodinated compounds in the blood after treatment with radioactive Iodine of functionally active metastases of the lungs.
    Nĕmec J; Bednár J; Vána S; Soumar J; Soutorová M
    Nucl Med (Stuttg); 1969 Oct; 8(3):275-82. PubMed ID: 4191345
    [No Abstract]   [Full Text] [Related]  

  • 5. Gadolinium as an alternative contrast agent during cardiac catheterization in patient with iodine-induced hyperthyroidism.
    Matuszczyk A; Hahn S; Böse D; Eggebrecht H; Schmermund A; Quadbeck B; Wieneke H; Petersenn S; Janssen OE; Mann K
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):336-8. PubMed ID: 16868894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of hyperthyroidism in examinations with contrast media].
    Hehrmann R; Klein D; Mayer D; Ploner O
    Aktuelle Radiol; 1996 Sep; 6(5):243-8. PubMed ID: 8991427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk to patients with latent or manifest hyperthyroidism through iodine-containing contrast media and drugs (author's transl)].
    Herrmann J; Krüskemper HL
    Dtsch Med Wochenschr; 1978 Sep; 103(37):1434, 1437-43. PubMed ID: 688870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iodine-induced hyperthyroidism in urology caused by using roentgen contrast media. Risks and prevention].
    Schürholz T; Schulze H
    Urologe A; 1993 Jul; 32(4):300-7. PubMed ID: 8372412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced thyrotoxic periodic paralysis.
    Kane MP; Busch RS
    Ann Pharmacother; 2006 Apr; 40(4):778-81. PubMed ID: 16537816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine-labeled proteins in the serum of patients treated with 131I for thyroid disease.
    Valenta L
    Endocrinol Exp; 1971 Jun; 5(3):127-42. PubMed ID: 5005942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unusually high iodine excretion in hyperthyroidism in an iodine-poor area].
    Reinwein D; Hackenberg K
    Schweiz Med Wochenschr; 1976 Mar; 106(11):377-80. PubMed ID: 1251155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of iodine deficiency upon PBI in hyperthyroidism.
    Pineda G; Silva E; Gianetti A; Stevenson C; Barzelatto J
    J Clin Endocrinol Metab; 1970 Jan; 30(1):120-4. PubMed ID: 5294083
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism.
    Rhee CM; Bhan I; Alexander EK; Brunelli SM
    Arch Intern Med; 2012 Jan; 172(2):153-9. PubMed ID: 22271121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cor thyreotoxicum. Part I--new findings about its etiopathogenesis and diagnosis. Overview of problems based on 35 years' experience].
    Hrnciar J
    Vnitr Lek; 2002 Jan; 48(1):38-44. PubMed ID: 11852586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protein-bound iodine in blood in thyrotoxicosis and myxedema].
    FRIIS T
    Ugeskr Laeger; 1954 Mar; 116(9):329-34. PubMed ID: 13157212
    [No Abstract]   [Full Text] [Related]  

  • 16. Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment.
    Bednár J; Nĕmec J; Soutorová M; Neradilová M; Pohunková D; Zamrazil V; Vána S; Havelka J; Röhling S
    Endocrinol Exp; 1979 Mar; 13(1):53-63. PubMed ID: 316382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Levels of serum protein iodine in peripheral venous blood and in returning thyroid blood in a group of hyperthyroid patients].
    Tornaghi A; Maggi GC; Damiani A
    Arch Ital Chir; 1968; 94(5):764-72. PubMed ID: 4184390
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperthyroidism induced by iodinated roentgen contrast media].
    van Guldener C; Blom DM; Lips P; Strack van Schijndel RJ
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1641-4. PubMed ID: 9763853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of protein-bound serum iodine during surgical treatment of diffuse toxic goiter].
    Titov VN; Parkhimovich RM
    Vestn Khir Im I I Grek; 1971 Feb; 106(2):7-10. PubMed ID: 5117972
    [No Abstract]   [Full Text] [Related]  

  • 20. Early changes of protein-bound iodine, butanol-extractable iodine, conversion factor and radioactive protein-bound iodine during treatment of thyrotoxicosis and thyroid cancer with 131-I.
    Bednár J; Nĕmec J; Soutorová M; Röhling S
    Nucl Med (Stuttg); 1969 Oct; 8(3):256-65. PubMed ID: 4191344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.